Nordhealth AS: Results of Share Buy Back

06 Dec 2023 18:06 CET

Reference is made to the stock exchange announcement on 30 November 2023, where
Nordhealth AS (the "Company") launched an offer to purchase up to 1,000,000 of
its own shares through a reverse book building process (the "Offering").

The application period expired at 16:30 hours (CET) on 6 December 2023.
Following the end of the application period, the Company has resolved to buy
992,624 shares at a price of NOK 23.00 per share, which equals approximately NOK
22.8 million in total.

All offers to sell shares with limits at or below NOK 23.00 have been allocated
in full.

Allocation notifications will be sent to shareholders having tendered shares in
the Offering on or about 7 December 2023. The trade date is expected to be on or
about 7 December 2023 and the settlement date is expected to be on or about 11
December 2023.

The settlement will be conducted on a normal delivery-versus-payment basis
(DVP). Following settlement of the Offering, the Company will own 1,146,637
shares in the Company. The Company currently has 80,191,746 shares outstanding.

For further information, please contact:

Carnegie AS

nordhealth@carnegie.no or +47 22 00 93 40

Charles Macbain, CEO

charles.macbain@nordhealth.com

Mari Orttenvuori, CFO

mari.orttenvuori@nordhealth.com

About Nordhealth

Nordhealth is a publicly listed, fast-growing cloud-based healthcare SaaS
company on a mission to redefine digital healthcare. We build software that
empower veterinary and therapy professionals to provide the best possible care
experiences to their patients. Our products serve more than 50,000 veterinary
and therapy professionals across 13,000 clinics and hospitals located in over 30
countries.

Headquartered in Helsinki, Finland, Nordhealth has a solid footprint in the
Nordic region and a growing presence internationally, with more than 380
employees working either remotely or from offices (collaboration hubs). Visit
the company's website at nordhealth.com (http://www.nordhealth.com).

More information:
Access the news on Oslo Bors NewsWeb site